Page 37 - P4304.1-V101_PS Magazine - Sept 24 PRINT
P. 37
Intended for UK healthcare professionals only
Testosterone Undecanoate Intramuscular Injection
A new addition to the Teva generics portfolio!
Testosterone Undecanoate is indicated for testosterone replacement therapy for male
hypogonadism when testosterone deficiency has been confirmed. 1
We know that low testosterone can cause a range of symptoms, such as fatigue, low sex drive, and muscle loss.
That is why we are committed to providing this treatment option for patients.
Key features of Testosterone Undecanoate
Long-lasting Eects: Patient convenience: By prescribing generically,
Testosterone Undecanoate can
Testosterone Undecanoate Longer dosing intervals may help help cost savings compared to the
intramuscular injection is known for its patient adherence. 2 brand originator price. 3*
extended release, reducing the
frequency of administration compared
to other testosterone formulations. 2
References:
1. Testosterone Undecanoate 1000 mg/4 ml Intramuscular Injection SmPC.
Teva UK Limited
2. Hackett, G. et al. (2023) ‘The British Society for Sexual Medicine
guidelines on male adult testosterone deficiency, with statements for
practice’, The World Journal of Men’s Health, 41(3),
p. 508. doi:10.5534/wjmh.221027.
3. Joint Formulary Committee. British National Formulary (online)
London: BMJ and Pharmaceutical Press - https://bnf.nice.org.uk/drugs/
testosterone-undecanoate/medicinal-forms/ [Last accessed March 2024]
* claim accurate as of 08/03/2024
Date of preparation: March 2024; Job code: GEN-GB-01204;
Registered in England No. 302461. Registered office: Teva UK Limited, Whistler Drive, Castleford, WF10 5HX. Copyright © 2024 Teva UK Limited T: 01977 628500 F: 01977 628799 www.tevauk.com
Adverse events should be reported. Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited on
0207 540 7117 or medinfo@tevauk.com.
07/08/2024 11:55:31
P4304.1-V101_PS Magazine - Sept 24.indd 37 07/08/2024 11:55:31
P4304.1-V101_PS Magazine - Sept 24.indd 37
